Immunex/Ivax Paclitaxel ANDA Is First To File; Hauser Will Supply Bulk Drug

FDA has confirmed that the Immunex/Ivax paclitaxel ANDA was the first to be filed, Ivax announced Aug. 13. The decision will give the companies 180 days of marketing exclusivity upon approval of the ANDA.